Model
Edge
Moonlake Immunotherapeutics
0001920785
Filing Type
4
Filing Date
6/11/2023
Updated
6/12/23, 10:57 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership